Cytokinetics, Incorporated

NasdaqGS:CYTK Stock Report

Market Cap: US$7.1b

Cytokinetics Balance Sheet Health

Financial Health criteria checks 2/6

Cytokinetics has a total shareholder equity of $-386.3M and total debt of $617.5M, which brings its debt-to-equity ratio to -159.8%. Its total assets and total liabilities are $824.3M and $1.2B respectively.

Key information

-159.8%

Debt to equity ratio

US$617.45m

Debt

Interest coverage ration/a
CashUS$614.82m
Equity-US$386.32m
Total liabilitiesUS$1.21b
Total assetsUS$824.32m

Recent financial health updates

Recent updates

Cytokinetics, Incorporated: Buyout Speculation Persists

Apr 01

Cytokinetics: CEO Talks Down Buyout Prospects

Mar 16

Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)

Jan 12

An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued

Oct 05
An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued

Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week

May 07
Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week

Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week

Mar 03
Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week

Cytokinetics, Incorporated's (NASDAQ:CYTK) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 20
Cytokinetics, Incorporated's (NASDAQ:CYTK) Intrinsic Value Is Potentially 100% Above Its Share Price

Newsflash: Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Have Been Trimming Their Revenue Forecasts

Dec 15
Newsflash: Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Have Been Trimming Their Revenue Forecasts

Cytokinetics: Surprise Adcomm For Omecamtiv Causing Concern

Oct 17

Cytokinetics gets monitoring panel's nod to continue phase 3 trial of ALS drug reldesemtiv

Oct 10

Cytokinetics (NASDAQ:CYTK) Has Debt But No Earnings; Should You Worry?

Aug 23
Cytokinetics (NASDAQ:CYTK) Has Debt But No Earnings; Should You Worry?

Financial Position Analysis

Short Term Liabilities: CYTK has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CYTK has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CYTK has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CYTK's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CYTK has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CYTK has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 32.3% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.